These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4354772)

  • 21. Studies in myasthenia gravis. Short-term massive corticotropin therapy.
    Osserman KE; Genkins G
    JAMA; 1966 Nov; 198(7):699-702. PubMed ID: 4288481
    [No Abstract]   [Full Text] [Related]  

  • 22. Isolated corticotroph insufficiency associated to myasthenia gravis.
    Corcuff JB; Lafranque P; Henry P; Roger P
    J Endocrinol Invest; 1997 Dec; 20(11):669-71. PubMed ID: 9492106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticotropin therapy in patients with myasthenia gravis. Electrophysiologic, pharmacologic studies.
    Namba T
    Arch Neurol; 1972 Feb; 26(2):144-50. PubMed ID: 4332732
    [No Abstract]   [Full Text] [Related]  

  • 24. Benefit from adrenocorticotrophin in myasthenia gravis.
    Liversedge LA; Yuill GM; Wilkinson IM; Hughes JA
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):412-5. PubMed ID: 4365243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STUDIES IN MYASTHENIA GRAVIS. PITUITARY-ADRENAL FUNCTION.
    KLEIN JJ; OSSERMAN KE
    N Engl J Med; 1964 Jul; 271():177-81. PubMed ID: 14158355
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnosis and treatment of ocular myasthenia (author's transl)].
    Huber A
    Klin Monbl Augenheilkd; 1977 Dec; 171(6):889-95. PubMed ID: 203742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled clinical trials of anything in myasthenia gravis.
    Pascuzzi RM
    Arch Neurol; 1997 Nov; 54(11):1323. PubMed ID: 9362974
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of subacute administration of discrete doses of ACTH in medium grade myasthenia. (Serial electromyographic study)].
    Pinelli P
    Riv Neurol; 1967; 37(4):343-65. PubMed ID: 4295653
    [No Abstract]   [Full Text] [Related]  

  • 29. Steroid therapy of myasthenia gravis.
    Vijayan N; Dreyfus PM
    West J Med; 1975 Aug; 123(2):130-1. PubMed ID: 170745
    [No Abstract]   [Full Text] [Related]  

  • 30. Short-term intensive corticotrophin treatment in myasthenia gravis.
    Liversedge LA
    Proc R Soc Med; 1971 May; 64(5):492. PubMed ID: 4325184
    [No Abstract]   [Full Text] [Related]  

  • 31. EMG analysis of myasthenic phenomena during the early deterioration and the improvement following ACTH treatment.
    Gandiglio G; Pinelli P
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):396-7. PubMed ID: 4176561
    [No Abstract]   [Full Text] [Related]  

  • 32. Corticotropin therapy in patients with myasthenia gravis: steroid metabolism, and histology of skeletal muscle and thymus.
    Namba T; Shapiro MS
    J Neurol Sci; 1972 Jun; 16(2):165-76. PubMed ID: 4338783
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of ACTH treatment on lymphocyte subpopulations in patients with myasthenia gravis.
    Smith E; Hammarstrom L; Möller E; Matell G
    Neurology; 1976 Oct; 26(10):915-8. PubMed ID: 183167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of myasthenia gravis.
    Flacke W
    N Engl J Med; 1973 Jan; 288(1):27-31. PubMed ID: 4347296
    [No Abstract]   [Full Text] [Related]  

  • 35. Corticotropin therapy in myasthenia gravis: indications and limitations.
    Namba T; Shapiro MS; Brunner NG; Grob D
    Neurology; 1970 Apr; 20(4):385. PubMed ID: 4327339
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the therapy of myasthenia gravis. (Presentation of a case)].
    Henriquet F; Balestra L
    Minerva Anestesiol; 1970 Apr; 36(4):277-81. PubMed ID: 4320560
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the relationship between negative effects and positive effects of ACTH therapy in myasthenic patients].
    Pinelli P; Gandiglio G
    Riv Neurol; 1968; 38(2):77-84. PubMed ID: 4298338
    [No Abstract]   [Full Text] [Related]  

  • 38. EMG analysis of myasthenic ACTH deterioration.
    Gandiglio G; Pinelli P
    Eur Neurol; 1968; 1(1):2-16. PubMed ID: 4301170
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe occult juvenile myasthenia gravis responsive to long-term corticosteroid therapy.
    Griggs RC; McFarlin DE; Engel WK
    Trans Am Neurol Assoc; 1968; 93():216-8. PubMed ID: 4304254
    [No Abstract]   [Full Text] [Related]  

  • 40. [Myasthenia gravis].
    Mozai T
    Naika; 1967 Jun; 19(6):1298-300. PubMed ID: 4295020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.